Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

Background: More than half of Chinese patients with hormone receptor positive (HR+) ductal carcinoma in situ (DCIS) are treated with mastectomy, and usually subjected to postoperative endocrine therapy (ET). Given that long-term ET can cause severe adverse effects it is important to determine the be...

Full description

Bibliographic Details
Main Authors: Nan Niu, Yinan Zhang, Yang Bai, Xin Wang, Shunchao Yan, Dong Song, Hong Xu, Tong Liu, Bin Hua, Yingchao Zhang, Jinchi Liu, Xinbo Qiao, Jiaxiang Liu, Xinyu Zheng, Hongyi Cao, Caigang Liu
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2023-02-01
Series:eLife
Subjects:
breast ductal carcinoma in situ
mastectomy
hormone receptor positive
endocrine therapy
disease-free survival
Online Access:https://elifesciences.org/articles/83045

Internet

https://elifesciences.org/articles/83045

Similar Items